ACACIA RESEARCH CORP

ITEM 5. OTHER INFORMATION

During thethree months ended September 30, 2026, no director or officer (as defined in Rule 16a-1(f) of the Exchange Act) of Acacia Research Corporation adopted, modified orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Amendment to Deflecto Credit Agreement

The information set forth below is included for the purpose of providing disclosure under “Item 1.01 — Entry into a Material Definitive Agreement” of Form 8-K.

On November 5, 2026, Deflecto entered into the Deflecto Credit Agreement Amendment, pursuant to which, among other things, (A) the total net leverage ratio covenant is not tested as of September 30, 2026 and December 31, 2026, (B) Deflecto is required to maintain a total net leverage ratio: (i)on or after March 31, 2027 and prior to March 31, 2028, not greater than 3.75 to 1.00, (ii)on or after March 31, 2028 and prior to June 30, 2028, not greater than 3.25 to 1.00, and (iii)on or after June 30, 2028, not greater than 2.75 to 1.00, (C) the minimum fixed charge coverage ratio covenant was removed, (D) Deflecto is required to keep minimum liquidityof no less than $10.0 million as of the end of each calendar month (calculated based on unrestricted cash on hand plus revolver availability under the Deflecto Facility), beginning December 31, 2026, (E) Deflecto is required to maintain a minimum EBITDA for the fiscal quarter ending December 31, 2026 of $(500,000), and (F) Deflecto agreed to prepay $17.0 million of the outstanding loan balance.

The foregoing description of the Deflecto Credit Agreement Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the Deflecto Credit Agreement Amendment, which is filed as Exhibit 10.1 to this Quarterly Report and is incorporated herein by reference.